maklogo
Market Research Report

Global Molecular Diagnostics Equipment Market Insights, Size, and Forecast By Application (Infectious Disease Diagnostics, Oncology Diagnostics, Genetic Testing, Transplantation Diagnostics, Reproductive Health Testing), By End Use (Hospitals, Diagnostic Laboratories, Research Institutions, Home Care Settings), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, In-Situ Hybridization, Microarray, Isothermal Nucleic Acid Amplification Technology), By Product Type (Instruments, Reagents, Software, Consumables), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:70519
Published Date:Jan 2026
No. of Pages:202
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Molecular Diagnostics Equipment Market is projected to grow from USD 28.7 Billion in 2025 to USD 71.3 Billion by 2035, reflecting a compound annual growth rate of 9.2% from 2026 through 2035. The molecular diagnostics equipment market encompasses instruments, reagents, and software utilized for the detection and analysis of biomarkers at a molecular level, primarily DNA, RNA, and proteins. This sophisticated technology plays a crucial role in disease diagnosis, prognosis, and treatment monitoring, offering unparalleled precision and sensitivity. Key market drivers include the rising global incidence of infectious diseases and chronic conditions, particularly cancer, which necessitate early and accurate diagnosis for effective patient management. Furthermore, advancements in genomic research, the increasing adoption of personalized medicine, and growing awareness of the benefits of molecular testing among healthcare professionals are significantly fueling market expansion. The market is segmented by technology, application, end use, and product type, indicating its diverse utility across various healthcare settings.

Global Molecular Diagnostics Equipment Market Value (USD Billion) Analysis, 2025-2035

maklogo
9.2%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

Important trends shaping the market include the growing integration of artificial intelligence and machine learning for enhanced diagnostic accuracy and workflow optimization. The development of point of care molecular diagnostics solutions is another significant trend, offering rapid results and improved accessibility, particularly in remote areas. However, market restraints include the high cost associated with molecular diagnostic equipment and tests, which can be a barrier to adoption in resource constrained regions. Additionally, stringent regulatory frameworks and the need for specialized infrastructure and trained personnel pose challenges to market penetration. Despite these hurdles, significant market opportunities exist in the development of novel diagnostic platforms for emerging infectious diseases and in expanding applications into areas such as companion diagnostics for targeted therapies and pharmacogenomics. North America currently dominates the market, driven by robust healthcare infrastructure, high healthcare expenditure, and a strong presence of key market players actively engaged in research and development.

Asia Pacific is emerging as the fastest growing region, propelled by increasing healthcare investments, a large patient pool, and improving access to advanced diagnostic technologies. The leading application segment is infectious disease diagnostics, accounting for a substantial share of the market due to the high global burden of infectious agents and the critical need for rapid and accurate detection to prevent outbreaks. Key players such as Qiagen, PerkinElmer, GenMark Diagnostics, Abbott Laboratories, Illumina, Agilent Technologies, Roche Diagnostics, F. HoffmannLa Roche, Siemens Healthineers, and BioRad Laboratories are focusing on strategic initiatives including product innovation, mergers and acquisitions, and collaborations to strengthen their market position and expand their geographic reach. These companies are investing heavily in R&D to develop next generation sequencing technologies, PCR based assays, and other advanced molecular diagnostic tools to address evolving healthcare needs. Their strategies also involve enhancing customer training and support to facilitate the wider adoption of molecular diagnostic solutions.

Quick Stats

  • Market Size (2025):

    USD 28.7 Billion

  • Projected Market Size (2035):

    USD 71.3 Billion

  • Leading Segment:

    Infectious Disease Diagnostics (52.8% Share)

  • Dominant Region (2025):

    North America (41.2% Share)

  • CAGR (2026-2035):

    9.2%

What is Molecular Diagnostics Equipment?

Molecular Diagnostics Equipment comprises specialized laboratory instruments that analyze biological samples for genetic material such like DNA or RNA. These devices detect specific molecular markers indicative of diseases, pathogens, or genetic predispositions. Key functions involve nucleic acid extraction, amplification via techniques like PCR, and detection often through sequencing or real time quantitative methods. Their significance lies in providing precise, sensitive, and rapid diagnostic information for various applications, including infectious disease testing, cancer diagnostics, genetic screening, and personalized medicine. This equipment revolutionized healthcare by enabling earlier, more accurate diagnoses and tailored treatment strategies based on an individual's unique molecular profile.

What are the Trends in Global Molecular Diagnostics Equipment Market

  • Point of Care MDx Expanding Reach

  • AI ML Integration for Enhanced Diagnostics

  • CRISPR Based Diagnostics Transforming Detection

  • Liquid Biopsy Advancements Reshaping Early Detection

Point of Care MDx Expanding Reach

Point of Care MDx Expanding Reach signifies the increasing availability and use of molecular diagnostic tests outside traditional central laboratories. These rapid, portable tests are now being performed closer to patients, such as in clinics, pharmacies, or even at home. This decentralization improves accessibility, accelerates diagnoses, and enables quicker treatment decisions, particularly for infectious diseases or genetic screening.

AI ML Integration for Enhanced Diagnostics

AI and ML are increasingly integrated into molecular diagnostics equipment, revolutionizing disease detection. This trend leverages sophisticated algorithms to analyze vast genetic and proteomic data sets, enabling earlier and more precise identification of pathogens, cancers, and genetic disorders. Such integration improves diagnostic accuracy, reduces false positives, personalizes treatment strategies, and optimizes laboratory workflows, ultimately leading to superior patient outcomes.

CRISPR Based Diagnostics Transforming Detection

CRISPR based diagnostics are revolutionizing disease detection. These technologies offer unparalleled precision, speed, and affordability, moving beyond traditional methods. Their ability to rapidly identify genetic material from pathogens and cancers means earlier, more accurate diagnoses. This transforms molecular diagnostics by enabling versatile, point of care testing, accelerating clinical decision making and improving patient outcomes globally.

Liquid Biopsy Advancements Reshaping Early Detection

Liquid biopsy advancements are revolutionizing early cancer detection by analyzing biomarkers in blood. This less invasive approach, leveraging technologies like next generation sequencing and PCR, offers the potential for earlier, more accurate diagnoses from a simple blood draw. It reduces reliance on invasive biopsies, leading to improved patient outcomes and expanded access to crucial early detection across diverse populations.

What are the Key Drivers Shaping the Global Molecular Diagnostics Equipment Market

  • Advancements in Molecular Technologies & Automation

  • Rising Incidence of Chronic & Infectious Diseases

  • Increasing Demand for Personalized Medicine & Point-of-Care Diagnostics

  • Growing Healthcare Expenditure & Government Initiatives

Advancements in Molecular Technologies & Automation

Breakthroughs in molecular biology and engineering are revolutionizing diagnostics. New technologies like advanced PCR, next generation sequencing, and digital platforms enable faster, more accurate, and multiplexed testing. Automation reduces manual errors and increases throughput, making these sophisticated tests more accessible and cost effective. This innovation pipeline consistently expands the range of detectable biomarkers and applications, fueling market growth.

Rising Incidence of Chronic & Infectious Diseases

The increasing prevalence of chronic conditions like cancer and diabetes, alongside the resurgence of infectious diseases such as COVID19 and tuberculosis, necessitates precise and early diagnosis. Molecular diagnostics offers superior accuracy and sensitivity for identifying pathogens and disease markers. This growing demand for reliable and rapid detection methods directly fuels the expansion of the molecular diagnostics equipment market.

Increasing Demand for Personalized Medicine & Point-of-Care Diagnostics

Rising patient expectations for tailored treatments and rapid, convenient diagnostic results fuel demand. This drives the adoption of molecular diagnostics capable of delivering individualized medicine solutions and enabling near patient testing, expanding the market for specialized equipment.

Growing Healthcare Expenditure & Government Initiatives

Rising healthcare spending globally fuels demand for advanced diagnostics. Governments actively invest in improving healthcare infrastructure and accessibility. These initiatives support the adoption of molecular diagnostics for early disease detection, personalized medicine, and improved patient outcomes. Increased funding and policy support are crucial drivers for market expansion.

Global Molecular Diagnostics Equipment Market Restraints

High Cost of Molecular Diagnostics Equipment

The substantial investment required for molecular diagnostics equipment significantly impedes market expansion. High purchase and maintenance costs create a barrier for smaller laboratories and healthcare facilities, particularly in developing regions. This financial burden restricts widespread adoption and limits the number of institutions able to offer advanced molecular testing. Consequently, the high cost curtails overall market growth by concentrating these capabilities in fewer, better-resourced centers globally.

Lack of Skilled Professionals for Equipment Operation

Operating sophisticated molecular diagnostics equipment demands specialized expertise. A global shortage of trained professionals capable of accurately using, maintaining, and interpreting results from these advanced instruments significantly hinders market expansion. This lack restricts the adoption and full utilization of innovative diagnostic technologies, particularly in emerging regions. Consequently, diagnostic services are limited, impacting accessibility and the overall growth trajectory of the molecular diagnostics equipment market.

Global Molecular Diagnostics Equipment Market Opportunities

Automation and AI Integration for High-Throughput Molecular Diagnostic Platforms

This opportunity focuses on integrating advanced automation and artificial intelligence into high throughput molecular diagnostic platforms. This enables unprecedented efficiency, significantly increasing sample processing capacity and accelerating result delivery. By minimizing human intervention and optimizing complex workflows, these integrated systems enhance accuracy and reduce operational costs. This innovation addresses the escalating global demand for rapid and precise disease detection, offering scalable solutions crucial for public health, infectious disease surveillance, oncology, and genetic testing, particularly beneficial in rapidly expanding markets like Asia Pacific.

Expansion of Decentralized and Point-of-Care Molecular Diagnostics

This opportunity drives molecular testing closer to patients, shifting from centralized labs to point of care settings. Decentralized molecular diagnostics offer rapid results, enabling quicker diagnosis and immediate treatment decisions. This expansion significantly improves accessibility to advanced testing, particularly vital in diverse geographical regions and underserved communities. It empowers healthcare providers to perform complex analyses conveniently, enhancing patient management and public health surveillance. Manufacturers can capitalize by developing innovative, user friendly, and portable diagnostic platforms tailored for widespread adoption in these crucial new environments.

Global Molecular Diagnostics Equipment Market Segmentation Analysis

Key Market Segments

By Technology

  • •Polymerase Chain Reaction
  • •Next-Generation Sequencing
  • •In-Situ Hybridization
  • •Microarray
  • •Isothermal Nucleic Acid Amplification Technology

By Application

  • •Infectious Disease Diagnostics
  • •Oncology Diagnostics
  • •Genetic Testing
  • •Transplantation Diagnostics
  • •Reproductive Health Testing

By End Use

  • •Hospitals
  • •Diagnostic Laboratories
  • •Research Institutions
  • •Home Care Settings

By Product Type

  • •Instruments
  • •Reagents
  • •Software
  • •Consumables

Segment Share By Technology

Share, By Technology, 2025 (%)

  • Polymerase Chain Reaction
  • Next-Generation Sequencing
  • In-Situ Hybridization
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology
maklogo
$28.7BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why is Infectious Disease Diagnostics dominating the Global Molecular Diagnostics Equipment Market?

Infectious Disease Diagnostics holds the largest share due to the critical global need for rapid and accurate identification of pathogens. The high prevalence of various infectious diseases, coupled with ongoing outbreaks and the imperative for effective disease management, drives substantial demand for molecular diagnostic equipment. Technologies like Polymerase Chain Reaction are extensively utilized for precise detection, enabling timely treatment and control measures across diverse healthcare settings.

Which technology segment is most impactful for the overall market growth?

Polymerase Chain Reaction technology is a cornerstone, significantly impacting market growth due to its widespread applicability, sensitivity, and specificity. PCR forms the foundation for countless diagnostic tests across infectious diseases, oncology, and genetic testing. Its continuous evolution, including real time PCR and multiplex PCR, ensures its sustained relevance and adoption, driving the demand for related instruments and reagents that facilitate its pervasive use in clinical laboratories.

How do End Use segments like Hospitals and Diagnostic Laboratories shape the market dynamics?

Hospitals and Diagnostic Laboratories are primary end users, exerting significant influence on market dynamics due to their high volume of patient samples and the critical need for advanced diagnostic capabilities. Hospitals rely on these solutions for immediate patient care decisions, while diagnostic laboratories serve as central hubs for comprehensive testing. Their substantial purchasing power and continuous investment in sophisticated instruments and reagents define demand trends and technology adoption rates across the molecular diagnostics landscape.

What Regulatory and Policy Factors Shape the Global Molecular Diagnostics Equipment Market

Global molecular diagnostics equipment faces stringent regulatory scrutiny from bodies like FDA, EMA under MDR, NMPA, and PMDA. These authorities mandate rigorous pre market approval, extensive clinical validation, and robust quality management systems like ISO 13485. Post market surveillance and adverse event reporting are critical for device lifecycle. Reimbursement policies, varying significantly by region, profoundly influence market access and adoption. Data privacy regulations such as GDPR and HIPAA also dictate operational compliance. While harmonization efforts exist through IMDRF, distinct regional requirements complicate market entry. Regulators continually adapt to rapid technological advancements, including AI and next generation sequencing, balancing innovation with patient safety and efficacy.

What New Technologies are Shaping Global Molecular Diagnostics Equipment Market?

The molecular diagnostics equipment market thrives on relentless innovation. Next Generation Sequencing NGS offers comprehensive genomic insights for oncology and rare diseases. Digital PCR provides unparalleled sensitivity for infectious disease detection and liquid biopsy. Point of Care POC molecular tests enable rapid decentralized diagnosis, expanding accessibility. CRISPR based diagnostics promise ultrafast and highly specific pathogen identification. Artificial intelligence and machine learning are revolutionizing data analysis, enhancing biomarker discovery and personalized medicine. Miniaturization, automation, and microfluidics are driving efficiencies and expanding multiplexing capabilities, making diagnostics faster, more accurate, and widely available across diverse healthcare settings.

Global Molecular Diagnostics Equipment Market Regional Analysis

Global Molecular Diagnostics Equipment Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
41.2%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

North America dominates the global molecular diagnostics equipment market with a 41.2% share, driven by a robust healthcare infrastructure, high awareness regarding early disease detection, and substantial R&D investments. The region benefits from a strong presence of key market players, advanced technological adoption, and favorable reimbursement policies. Increased prevalence of chronic diseases and cancer, coupled with a rising demand for personalized medicine and precision diagnostics, further fuels market expansion. High per capita healthcare expenditure and a focus on genetic testing and infectious disease diagnostics also significantly contribute to its leading position.

Europe holds a significant share in the Molecular Diagnostics Equipment Market, driven by robust healthcare infrastructure, high prevalence of chronic and infectious diseases, and strong R&D investments. Germany, France, and the UK lead, demonstrating rapid adoption of advanced diagnostics like PCR, NGS, and microarrays. The region benefits from strong regulatory frameworks that foster innovation and quality. Expanding applications in oncology, infectious disease testing, and companion diagnostics further fuel growth. Aging populations and increasing demand for personalized medicine contribute to sustained market expansion across Western and Nordic European countries, with Eastern Europe gradually catching up due to improving healthcare access.

The Asia Pacific region is the fastest-growing in the molecular diagnostics equipment market, projected to achieve an 11.2% CAGR. This surge is fueled by increasing healthcare expenditure, rising awareness of early disease detection, and a growing prevalence of infectious diseases and cancer. Key drivers include government initiatives to improve healthcare infrastructure, the expanding elderly population, and the adoption of advanced diagnostic technologies. Countries like China, India, and Japan are leading this growth, with significant investments in R&D and a burgeoning domestic manufacturing base. The region also benefits from the increasing availability of affordable diagnostic tests and a large patient pool.

Latin America's molecular diagnostics equipment market shows robust growth due to rising chronic disease prevalence, particularly infectious diseases like dengue and zika, and increased cancer diagnoses. Brazil, Mexico, and Argentina are key markets, driven by government healthcare spending and private sector investment in advanced diagnostic technologies. Adoption of point-of-care testing and next-generation sequencing is expanding, though high equipment costs and limited access in rural areas remain challenges. Local manufacturing is nascent, with imports dominating. The region's aging population and growing awareness of personalized medicine will further fuel market expansion, attracting more international players and fostering technological advancements.

MEA Molecular Diagnostics Equipment Market is experiencing rapid growth, driven by increasing prevalence of infectious diseases (HIV, TB) and genetic disorders. Saudi Arabia, UAE, and South Africa lead in adoption of advanced diagnostics due to established healthcare infrastructure and rising healthcare expenditure. Government initiatives focused on early disease detection and improving diagnostic capabilities further propel market expansion. Technological advancements, including next-generation sequencing and point-of-care testing, are gaining traction, especially in remote areas. Challenges include limited accessibility to specialized testing in rural regions and cost constraints, though these are being addressed through public-private partnerships and increased investment in healthcare infrastructure.

Top Countries Overview

The United States dominates the global molecular diagnostics equipment market. Its strong research infrastructure, significant healthcare spending, and rapid adoption of advanced technologies drive this growth. Key market players thrive amidst increasing demand for personalized medicine and early disease detection, particularly in oncology and infectious diseases.

China's molecular diagnostics equipment market is expanding rapidly, driven by technological advancements and increased healthcare spending. Domestic manufacturers are growing, competing with international players. The market focuses on infectious diseases, cancer, and prenatal screening, with a rising demand for automation and point of care solutions, influencing global trends.

India's molecular diagnostics market is burgeoning, fueled by rising infectious disease burden and cancer rates. Increased healthcare spending, technological advancements, and government initiatives are driving adoption of sophisticated equipment. Global players view India as a key growth region for molecular diagnostics, expanding their presence and product portfolios.

Impact of Geopolitical and Macroeconomic Factors

Escalating healthcare expenditures and a rising burden of infectious diseases globally are key geopolitical drivers. Government funding for public health initiatives and pandemic preparedness significantly influences market expansion, particularly in emerging economies where diagnostic infrastructure is rapidly evolving. Political stability and international collaborations on disease surveillance also shape market access and technology adoption.

Macroeconomic factors include healthcare spending per capita and economic growth rates, impacting purchasing power for advanced equipment. Inflationary pressures on raw materials and manufacturing, coupled with currency fluctuations, can influence equipment pricing and accessibility. Reimbursement policies and private healthcare investment further dictate market demand and manufacturers' profitability.

Recent Developments

  • March 2025

    Illumina announced a strategic partnership with GenMark Diagnostics to integrate GenMark's rapid syndromic panel testing capabilities with Illumina's next-generation sequencing platforms. This collaboration aims to offer comprehensive diagnostic solutions, combining speed for acute care with high-throughput genomic analysis for broader pathogen identification and characterization.

  • January 2025

    Abbott Laboratories launched its new Alinity m-Resp-4-plex assay, an advanced molecular diagnostic test capable of simultaneously detecting and differentiating influenza A, influenza B, RSV, and SARS-CoV-2. This product launch enhances Abbott's existing Alinity m portfolio, providing healthcare providers with a highly efficient tool for respiratory pathogen identification during peak seasons.

  • February 2025

    Qiagen completed the acquisition of a specialized diagnostics technology startup focused on microfluidic-based molecular assays for point-of-care testing. This acquisition strengthens Qiagen's position in the decentralized diagnostics market, adding innovative rapid testing capabilities to its diverse product offerings.

  • April 2025

    Roche Diagnostics announced a significant expansion of its manufacturing capacity for PCR and next-generation sequencing reagents in North America and Europe. This strategic initiative aims to meet the growing global demand for molecular diagnostic testing, ensuring a robust supply chain for its key customers and partners worldwide.

  • May 2025

    PerkinElmer introduced the EnSight™ Automated Molecular Workflow System, a fully integrated solution designed to automate high-throughput molecular diagnostic testing from sample preparation to result interpretation. This product launch targets clinical laboratories seeking to improve efficiency and reduce manual errors in their molecular diagnostics operations.

Key Players Analysis

The global molecular diagnostics equipment market sees dominant players like Roche Diagnostics and Abbott Laboratories leveraging extensive product portfolios and established market presence. Illumina and Qiagen are crucial innovators, driving growth through next generation sequencing and PCR technologies respectively. Strategic initiatives include acquisitions like PerkinElmer acquiring companies to expand diagnostic capabilities and Siemens Healthineers focusing on automated platforms. GenMark Diagnostics and BioRad Laboratories contribute with multiplex PCR and advanced immunoassay systems, while Agilent Technologies provides critical research and clinical tools. These companies collectively drive market expansion through technological advancements, increasing demand for personalized medicine, and the need for rapid infectious disease detection.

List of Key Companies:

  1. Qiagen
  2. PerkinElmer
  3. GenMark Diagnostics
  4. Abbott Laboratories
  5. Illumina
  6. Agilent Technologies
  7. Roche Diagnostics
  8. F. HoffmannLa Roche
  9. Siemens Healthineers
  10. BioRad Laboratories
  11. Cepheid
  12. Thermo Fisher Scientific
  13. Luminex
  14. Hologic
  15. Diagnostics For All

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 28.7 Billion
Forecast Value (2035)USD 71.3 Billion
CAGR (2026-2035)9.2%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Technology:
    • •Polymerase Chain Reaction
    • •Next-Generation Sequencing
    • •In-Situ Hybridization
    • •Microarray
    • •Isothermal Nucleic Acid Amplification Technology
  • By Application:
    • •Infectious Disease Diagnostics
    • •Oncology Diagnostics
    • •Genetic Testing
    • •Transplantation Diagnostics
    • •Reproductive Health Testing
  • By End Use:
    • •Hospitals
    • •Diagnostic Laboratories
    • •Research Institutions
    • •Home Care Settings
  • By Product Type:
    • •Instruments
    • •Reagents
    • •Software
    • •Consumables
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Molecular Diagnostics Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Technology
5.1.1. Polymerase Chain Reaction
5.1.2. Next-Generation Sequencing
5.1.3. In-Situ Hybridization
5.1.4. Microarray
5.1.5. Isothermal Nucleic Acid Amplification Technology
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.2.1. Infectious Disease Diagnostics
5.2.2. Oncology Diagnostics
5.2.3. Genetic Testing
5.2.4. Transplantation Diagnostics
5.2.5. Reproductive Health Testing
5.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
5.3.1. Hospitals
5.3.2. Diagnostic Laboratories
5.3.3. Research Institutions
5.3.4. Home Care Settings
5.4. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
5.4.1. Instruments
5.4.2. Reagents
5.4.3. Software
5.4.4. Consumables
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Molecular Diagnostics Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Technology
6.1.1. Polymerase Chain Reaction
6.1.2. Next-Generation Sequencing
6.1.3. In-Situ Hybridization
6.1.4. Microarray
6.1.5. Isothermal Nucleic Acid Amplification Technology
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.2.1. Infectious Disease Diagnostics
6.2.2. Oncology Diagnostics
6.2.3. Genetic Testing
6.2.4. Transplantation Diagnostics
6.2.5. Reproductive Health Testing
6.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
6.3.1. Hospitals
6.3.2. Diagnostic Laboratories
6.3.3. Research Institutions
6.3.4. Home Care Settings
6.4. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
6.4.1. Instruments
6.4.2. Reagents
6.4.3. Software
6.4.4. Consumables
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Molecular Diagnostics Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Technology
7.1.1. Polymerase Chain Reaction
7.1.2. Next-Generation Sequencing
7.1.3. In-Situ Hybridization
7.1.4. Microarray
7.1.5. Isothermal Nucleic Acid Amplification Technology
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.2.1. Infectious Disease Diagnostics
7.2.2. Oncology Diagnostics
7.2.3. Genetic Testing
7.2.4. Transplantation Diagnostics
7.2.5. Reproductive Health Testing
7.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Research Institutions
7.3.4. Home Care Settings
7.4. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
7.4.1. Instruments
7.4.2. Reagents
7.4.3. Software
7.4.4. Consumables
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Molecular Diagnostics Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Technology
8.1.1. Polymerase Chain Reaction
8.1.2. Next-Generation Sequencing
8.1.3. In-Situ Hybridization
8.1.4. Microarray
8.1.5. Isothermal Nucleic Acid Amplification Technology
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.2.1. Infectious Disease Diagnostics
8.2.2. Oncology Diagnostics
8.2.3. Genetic Testing
8.2.4. Transplantation Diagnostics
8.2.5. Reproductive Health Testing
8.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Research Institutions
8.3.4. Home Care Settings
8.4. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
8.4.1. Instruments
8.4.2. Reagents
8.4.3. Software
8.4.4. Consumables
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Molecular Diagnostics Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Technology
9.1.1. Polymerase Chain Reaction
9.1.2. Next-Generation Sequencing
9.1.3. In-Situ Hybridization
9.1.4. Microarray
9.1.5. Isothermal Nucleic Acid Amplification Technology
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.2.1. Infectious Disease Diagnostics
9.2.2. Oncology Diagnostics
9.2.3. Genetic Testing
9.2.4. Transplantation Diagnostics
9.2.5. Reproductive Health Testing
9.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
9.3.1. Hospitals
9.3.2. Diagnostic Laboratories
9.3.3. Research Institutions
9.3.4. Home Care Settings
9.4. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
9.4.1. Instruments
9.4.2. Reagents
9.4.3. Software
9.4.4. Consumables
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Molecular Diagnostics Equipment Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Technology
10.1.1. Polymerase Chain Reaction
10.1.2. Next-Generation Sequencing
10.1.3. In-Situ Hybridization
10.1.4. Microarray
10.1.5. Isothermal Nucleic Acid Amplification Technology
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.2.1. Infectious Disease Diagnostics
10.2.2. Oncology Diagnostics
10.2.3. Genetic Testing
10.2.4. Transplantation Diagnostics
10.2.5. Reproductive Health Testing
10.3. Market Analysis, Insights and Forecast, 2020-2035, By End Use
10.3.1. Hospitals
10.3.2. Diagnostic Laboratories
10.3.3. Research Institutions
10.3.4. Home Care Settings
10.4. Market Analysis, Insights and Forecast, 2020-2035, By Product Type
10.4.1. Instruments
10.4.2. Reagents
10.4.3. Software
10.4.4. Consumables
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. Qiagen
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. PerkinElmer
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. GenMark Diagnostics
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. Abbott Laboratories
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Illumina
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. Agilent Technologies
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Roche Diagnostics
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. F. HoffmannLa Roche
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Siemens Healthineers
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. BioRad Laboratories
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Cepheid
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. Thermo Fisher Scientific
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Luminex
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. Hologic
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. Diagnostics For All
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 2: Global Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 3: Global Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 4: Global Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 5: Global Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 7: North America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 8: North America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 9: North America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 10: North America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 12: Europe Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 13: Europe Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 14: Europe Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 15: Europe Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 17: Asia Pacific Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 18: Asia Pacific Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 19: Asia Pacific Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 20: Asia Pacific Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 22: Latin America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 23: Latin America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 24: Latin America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 25: Latin America Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Technology, 2020-2035

Table 27: Middle East & Africa Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 28: Middle East & Africa Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by End Use, 2020-2035

Table 29: Middle East & Africa Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Product Type, 2020-2035

Table 30: Middle East & Africa Molecular Diagnostics Equipment Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Healthcare Market Research

Explore comprehensive market research reports covering all aspects of the Healthcare industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;